The research examining medicinal cannabis so far have found it to be potentially beneficial for the treatment of the following conditions:
Studies have shown cannabis can help slow the production of beta-amyloid proteins, which are considered a key contributor to the progression of Alzheimer’s disease.
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease)
Studies have shown cannabis effectively slows the progression of the disease and helps patients manage the disease’s associated symptoms.
Studies have shown cannabis to be an effective treatment for some aspects of the disorder, and several states have approved medical cannabis as a treatment.
Studies have shown cannabis can reduce autonomic arousal and subjective anxiety.
Studies have shown cannabis can help curtail the pain, sleeping problems and spasms often associated with the condition.
Studies have shown cannabis can help repair the brain’s ability to send clear signals, thus improve behavior and communication.
Studies have shown cannabis can boost bone density and assist in healing.
Cachexia (Wasting Syndrome)
Studies have shown cannabis boosts appetite and increases body weight and energy levels.
Studies have shown cannabis has the capability of helping cancer patients manage the nausea, pain and weight loss related to cancer treatments, and even limit the growth or kill cancer cells.
Studies have shown cannabis can protect against hypertension, stroke, atherosclerosis and heart attacks by causing blood vessels to vasodilate (relax and widen).
Central Nervous System Disorders
Studies have shown cannabis provides neuroprotective effects.
Studies have shown cannabis is highly effective at lowering all types of pain, including the pain that’s shown to be resistant to other treatments.
Cirrhosis and Liver Disorders
Studies show that a cannabinoid found in cannabis can help combat the progression of cirrhosis and other liver disorders.
Studies have shown cannabis has antidepressant-like effects.
Studies have shown cannabis reduces the risk of diabetes, can help treat diabetes once its developed, and assists in the management of pain associated with the disease.
Studies have shown cannabis can reduce dystonic movements.
Early Morning Disorder
Studies have shown cannabis improves sleep.
Epilepsy (Including Dravet Syndrome, Lennox-Gastaut Syndrome)
Studies have shown a major cannabinoid found in cannabis is effective at significantly decreasing the frequency of seizures and has the potential of offering complete seizure freedom.
Studies have shown cannabis effectively lowers pain levels and improves quality of sleep in patients.
Studies have shown cannabis can help manage pain associated with the disorder.
Studies have shown cannabis decreases intraocular pressure.
Hepatitis C Virus
Studies have shown cannabis shows potential as an anti-inflammatory treatment and helps patients manage symptoms associated with the virus.
Studies have shown cannabis reduces withdrawal symptoms and therefore can be used in the early treatment for addiction.
Studies have shown cannabis helps make side effects of HIV/AIDS treatment more manageable.
Studies have shown that cannabis helps improve the secondary symptoms associated with the condition.
Inflammatory Bowel Disease (Crohn’s Disease, Ulcerative Colitis)
Studies have shown cannabis is effective at decreasing digestive tract inflammation and in some cases can help patients achieve long-term remission.
Studies have shown cannabis stimulates leukemia cell death and assists in the management of symptoms associated with cancer and traditional cancer treatments.
Studies have shown cannabis reduces inflammation and pain caused by the disease.
Studies have shown cannabis reduces pain caused by migraines.
Studies have shown cannabis is effective at helping patients manage symptoms associated with the disease.
Multiple Sclerosis (MS)
Studies have shown cannabis reduces pain and muscle spasms associated with multiple sclerosis and helps slow the disease’s progression.
Studies have shown cannabis helps reduce pain and involuntary muscle contractions.
Studies have shown cannabis can reduce pain and lower the risk and progression of glaucoma and kidney disease, which can develop from nail-patella syndrome.
Studies have shown cannabis helps curtail nausea once it’s developed and helps reduce anticipatory nausea.
Studies have shown cannabis has neuro-protective benefits and helps reduce pain associated with the disorders.
Studies have shown cannabis can produce weight loss.
Studies have shown cannabis reduces ocular toxicity and can protect the retina from degeneration damage.
Studies have shown cannabis reduces the progression of Parkinson’s disease and helps manage associated symptoms.
Post-Traumatic Stress Disorder (PTSD)
Studies have shown cannabis can lessen the emotional impact of traumatic events, reduce anxiety and fear, and improve sleep.
Studies have shown cannabis can reduce inflammation and thus potentially help treat arthritis.
Studies have shown that cannabidiol, found in cannabis, can serve as an antipsychotic treatment.
Sickle Cell Anemia
Studies have shown cannabis lowers pain caused by the disorder and helps maintain proper blood flow.
Studies have shown cannabis effectively reduces the frequency and intensity of spasms.
Studies have shown cannabis helps patients manage spasms, seizures and pain.
Spinal Cord Disease
Studies have shown cannabis improves pain, sleep, and spasms that arise.
Spinal Cord Injuries
Studies have shown cannabis can limit neurological damage when administered shortly after the moment of trauma and later help manage pain and spasms.
Studies have shown cannabis can help reduce pain, sleeping problems and spasms associated with the condition.
Studies have shown cannabis can limit brain damage and improves recovery when administered shortly after a stroke.
Studies have shown cannabis can safely reduce the frequency of tics.
Traumatic Brain Injury (TBI)
Studies have shown cannabis can limit brain damage and improves recovery when it’s administered shortly after the traumatic blow.
Studies have shown cannabis has demonstrated antitumor effects.
Get more info or order your Products at www.cbdHealingLives.com
Abrams, D.I., Jay, C.A., Shade, S.B., Vizoso, H., Reda, H., Press, S., Kelly, M.E., Rowbotham, MC. and Petersen, KL. (2007, February). Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology, 68(7), 515-21.
Aggarwal, S.K., Carter, G.T., Sullivan, M.D., ZumBrunnen, C., Morrill, R., and Mayer, J.D. (2009, May-June). Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. Journal of Opioid Management, 5(3), 153-68.
Bar-Sela, G., Vorobeichik, M., Drawsheh, S., Omer, A., Goldberg, V., and Muller, E. (2013). The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care. Evidence-Based Complementary and Alternative Medicine, 2013, 510392. Retrieved from http://www.hindawi.com/journals/ecam/2013/510392/.
Blair, R.E., Deshpande, L.S., and DeLorenzo, R.J. (2015, September). Cannabinoids: is there a potential treatment role in epilepsy? Expert Opinion on Pharmacology, 16(13), 1911-4.
Di Marzo, V., Bifulco, M., and De Petrocellis, L. (2004, September). The endocannabinoid system and its therapeutic exploitation. Nature Reviews, 3(9), 771-84.
Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., and Izzo, A.A. (2004, April). Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. Journal of Neurochemistry, 89(1), 134-41.
Kalant, H., and Porath-Waller, A.J. (2014). Clearing the smoke on cannabis: medical use of cannabis and cannabinoids. Canadian Centre on Substance Abuse. Retrieved from http://www.ccsa.ca/…/CCSA-Medical-Use-of-Cannabis-2012-en.p….
Lakhan S.E., and Rowland M. (2009). Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurology, 9(59), doi:10.1186/1471-2377-9-59.
Latini, L., Bisicchia, E., Sasso, V., Chiurchiu, V., Cavallucci, V., Molinari, M., Maccarrone, M., and Viscomi, M.T. (2014, September 4). Cannabinoid CB2 receptor (CB2R). stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation. Cell Death & Disease, e1404.
McAllister, S.D., Soroceanu, L., and Desprez, P.Y. (2015, June). The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. Journal of Neuroimmune Pharmacology, 10(2), 255-67.
Mechoulam, R., and Shohami, E. (2007, August). Endocannabinoids and traumatic brain injury. Molecular Neurobiology, 36(1), 68-74.
Cannabinoids Research. (2015). Americans For Safe Access. Retrieved from http://www.safeaccessnow.org/medical_cannabis_research_what….
More, S.V., and Choi, D.K. (2015, April). Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection. Molecular Neurodegeneration, 10, 17.
Pacher, P., Batkai, S., and Kunos, G. (2006, September). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews, 58(3), 389-462.
Pertwee, R.G. (2006, January). Cannabinoid pharmacology: the first 66 years. British Journal of Pharmacology, 147(Suppl 1), S163-S171.
Russo, E.B., Mead, A.P., and Sulak, D. (2015, April). Current Status and Future of Cannabis Research. Clinical Researcher. Retrieved from http://cannabisclinicians.org/…/Russo-et-al-Current-status-….
Zuardi, A.W. (2006, June). History of cannabis as a medicine: a review. Revista Brasileira de Psiquiatria, 28(2), 153-7.
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 510392, 8 pages
Research Article: https://www.hindawi.com/journals/ecam/2013/510392/